US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class III · Low risk Terminated

Simvastatin Tablets

Reason Presence of foreign substance: metallic razor blade was found in one bottle.

Hetero Labs, Ltd. - Unit III NDC 31722-513-10 D-0223-2018
Class III · Low risk Terminated

Clobetasol Propionate Cream USP

Reason Failed Content Uniformity Specifications

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1258-3 D-0249-2018
Class II · Moderate risk Terminated

DELFLEX Peritoneal Dialysis Solution

Reason Lack of Assurance of Sterility: Leakage of the peritoneal dialysis (PD) solution bag.

Fresenius Medical Care Renal Therapies Group, LLC NDC 49230-209-30 D-0604-2018
Class I · High risk Terminated

Linezolid Injection 600 mg/300 mL

Reason Presence of Particulate Matter; white particulate matter identified as mold was found in one bag

AuroMedics Pharma LLC NDC 55150-242-51 D-0337-2018
Class II · Moderate risk Terminated

Dry to Normal Skin Starter Kit

Reason Failed Stability Specifications:stability failure at 12 months, long term RT conditions.

Odan Laboratories Ltd D-0232-2018
Class II · Moderate risk Terminated

Day Cream SPF15 Cr¿me de jour FPS 15

Reason Failed Stability Specifications:stability failure at 12 months, long term RT conditions.

Odan Laboratories Ltd D-0231-2018
Class II · Moderate risk Terminated

Divalproex Sodium Delayed Release Tablets USP

Reason Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.

Unichem Pharmaceuticals Usa Inc NDC 29300-140-01 D-0228-2018
Class II · Moderate risk Terminated

Fosphenytoin Sodium Injection

Reason Presence of particulate matter

Amneal Pharmaceuticals NDC 70121-1390-1 D-0610-2018
Class III · Low risk Terminated

Gabapentin Oral Solution

Reason CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.

Akorn Inc D-0211-2018
Class II · Moderate risk Terminated

0.25% Acetic Acid Irrigation USP

Reason Presence of Particulate Matter: identified as polyethylene, which is consistent with the material used to manufacture the contain cap

B. Braun Medical Inc NDC 0264-2304-10 D-0112-2018
Class II · Moderate risk Terminated

SPIRIVA HandiHaler

Reason Failed Stability Specifications

Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0075-47 D-0242-2018
Class II · Moderate risk Terminated

Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP

Reason Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.

Teva Pharmaceuticals USA NDC 0093-5213-01 D-0208-2018
Class II · Moderate risk Terminated

INFeD

Reason Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.

Allergan NDC 52544-931-07 D-0545-2018
Class III · Low risk Terminated

Auryxia

Reason Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.

Keryx Biopharmaceuticals, Inc. NDC 59922-631-01 D-0133-2018
Class II · Moderate risk Terminated

Neutrogena Elevated 4-Holiday Trays

Reason Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.

Johnson & Johnson D-0245-2018
Class II · Moderate risk Terminated

Neutrogena deep clean purifying whipped foam cleanser

Reason Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.

Johnson & Johnson D-0244-2018